Directory
>
Melissa Calton
Melissa Calton
Vice President, Early-Stage Product Development | 4D Molecular Therapeutics
San Francisco, California, United States
Melissa Calton
Summary
Melissa Calton is a seasoned professional with extensive experience in drug development across various therapeutic areas, particularly within the biopharmaceutical sector. As the Vice President of Early-Stage Product Development at 4D Molecular Therapeutics, she has demonstrated her ability to lead cross-functional teams and drive innovative solutions in complex programs. Her academic background includes a postdoctoral fellowship at Stanford University, where she specialized in genetics, and a PhD in Pharmaceutical Sciences from UCSF. Melissa is recognized for her strategic thinking and results-oriented approach, making her a trusted partner to executive teams. In addition to her leadership roles, she has a rich publication record, showcasing her contributions to the field of genetics and ophthalmology. Outside of her professional achievements, Melissa's interests lie in advancing drug discovery and development, particularly in addressing ocular diseases. Her commitment to innovation and collaboration positions her as a key player in the biopharmaceutical landscape.
Melissa Calton
Work Experience
Vice President, Early-Stage Product Development at
4D Molecular Therapeutics
October 2023 - Present
Senior Director, Head of Early-Stage Product Development at
4D Molecular Therapeutics
July 2023 - October 2023
Senior Director, Translational Medicine- Project Team Leader at
4D Molecular Therapeutics
July 2022 - July 2023
Interim Head of Development at
4D Molecular Therapeutics
February 2023 - July 2023
Director, Translational Medicine/Preclinical, Program Leader at
4D Molecular Therapeutics
December 2020 - July 2022
Associate Director, Translational Medicine, Program Leader at
4D Molecular Therapeutics
October 2019 - December 2020
Senior Scientist, Program Manager of Ophthalmology at
Verseon
August 2018 - October 2019
Scientist at
Verseon
September 2016 - August 2018
Postdoctoral Scholar at
Stanford University
January 2011 - August 2016
PhD Candidate at
University Of California San Francisco
August 2005 - December 2010
Melissa Calton
Education
Stanford University, Postdoctoral Scholar
January 2011 - January 2016
University of California, San Francisco, Phd
January 2005 - January 2010
January 1998 - January 2002
Frequently Asked Questions about Melissa Calton
What is Melissa Calton email address?
Melissa Calton's primary email address is *******@4dmoleculartherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Melissa Calton work for?
Melissa Calton is a Vice President, Early-Stage Product Development at 4D Molecular Therapeutics, a company specializing in Commercial physical research.
Where Melissa Calton graduated from?
Melissa Calton holds a degree in Genetics from Stanford University.
How can I directly contact Melissa Calton?
To contact Melissa Calton directly, you can use the email address *******@4dmoleculartherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Melissa Calton?
Melissa Calton is a seasoned professional with extensive experience in drug development across various therapeutic areas, particularly within the biopharmaceutical sector. As the Vice President of Early-Stage Product Development at 4D Molecular Therapeutics, she has demonstrated her ability to lead cross-functional teams and drive innovative solutions in complex programs. Her academic background includes a postdoctoral fellowship at Stanford University, where she specialized in genetics, and a PhD in Pharmaceutical Sciences from UCSF. Melissa is recognized for her strategic thinking and results-oriented approach, making her a trusted partner to executive teams. In addition to her leadership roles, she has a rich publication record, showcasing her contributions to the field of genetics and ophthalmology. Outside of her professional achievements, Melissa's interests lie in advancing drug discovery and development, particularly in addressing ocular diseases. Her commitment to innovation and collaboration positions her as a key player in the biopharmaceutical landscape.
Melissa`s contact details
*******@4dmoleculartherapeutics.com
Colleagues
Chief Legal Officer
Chief Of Staff
Senior Vice President - Clinical Development, Therapeutic Area Head - Pulmonology
Chief Research & Translational Development Officer
Chief Medical Officer
SVP, Clinical Development Operations
Board Member
Executive Business Partner, CEO Office
Senior Vice President
Co-Founder & Board Director: Life Sciences Entrepreneurship Center